Norges Bank Makes New Investment in USANA Health Sciences, Inc. (NYSE:USNA)

Norges Bank acquired a new stake in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 26,549 shares of the company's stock, valued at approximately $953,000. Norges Bank owned 0.14% of USANA Health Sciences at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. R Squared Ltd bought a new position in USANA Health Sciences in the fourth quarter worth about $28,000. KLP Kapitalforvaltning AS bought a new position in shares of USANA Health Sciences in the 4th quarter worth approximately $83,000. Quantbot Technologies LP purchased a new position in shares of USANA Health Sciences in the 4th quarter valued at approximately $132,000. Amundi boosted its position in shares of USANA Health Sciences by 85.3% during the fourth quarter. Amundi now owns 4,872 shares of the company's stock valued at $170,000 after purchasing an additional 2,243 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its holdings in USANA Health Sciences by 11.3% in the fourth quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company's stock worth $308,000 after purchasing an additional 869 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

USNA has been the topic of a number of research reports. StockNews.com cut shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Sidoti lowered shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, February 18th. Finally, DA Davidson decreased their target price on shares of USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research note on Thursday, February 27th.

Insider Transactions at USANA Health Sciences

In other news, insider Joshua Foukas sold 5,732 shares of the business's stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $32.54, for a total transaction of $186,519.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider David Mulham Mulham sold 3,234 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $32.98, for a total transaction of $106,657.32. Following the completion of the sale, the insider now owns 12,775 shares in the company, valued at $421,319.50. This represents a 20.20 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,920 shares of company stock worth $500,285 over the last quarter. 0.33% of the stock is currently owned by insiders.

USANA Health Sciences Price Performance

USANA Health Sciences stock traded up $0.29 during mid-day trading on Thursday, reaching $23.72. The stock had a trading volume of 39,956 shares, compared to its average volume of 117,135. The company has a market capitalization of $448.43 million, a price-to-earnings ratio of 8.38, a PEG ratio of 0.93 and a beta of 1.00. USANA Health Sciences, Inc. has a one year low of $23.28 and a one year high of $49.78. The company has a 50-day moving average price of $28.73 and a two-hundred day moving average price of $33.76.

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, beating analysts' consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The firm had revenue of $213.61 million for the quarter, compared to analysts' expectations of $208.82 million. On average, equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.